Submission Details
| 510(k) Number | K162620 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 20, 2016 |
| Decision Date | May 01, 2017 |
| Days to Decision | 223 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K162620 is an FDA 510(k) clearance for the Remel Spectra ESBL, a Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar (Class II — Special Controls, product code JSO), submitted by Remel, Inc. (Lenexa, US). The FDA issued a Cleared decision on May 1, 2017, 223 days after receiving the submission on September 20, 2016. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.1700.
| 510(k) Number | K162620 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 20, 2016 |
| Decision Date | May 01, 2017 |
| Days to Decision | 223 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | JSO — Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.1700 |